Our projects

Censis, the Scotland 5G Centre, and DHI conducted a feasibility study in Moray to explore 5G opportunities for Health and Care services. The study identified key success factors for a community health network and highlighted the potential for service enhancement through 5G technology.

This 4-year, €6 million Horizon Europe programme includes NHS Highland, the University of Edinburgh, and the University of Strathclyde. It aims to replace up to 75% of optical colonoscopies with Camera Capsule Endoscopy (CCE), enhancing patient experience and hospital efficiency by using AI to streamline diagnostics and reduce errors.

The AIM4ALL Proof of Concept aimed to enhance data collection for evaluating new healthcare products in Scotland, using CAR T-cell therapy as an example. The project was a partnership between DHI, Precision Medicine, and NHS Greater Glasgow and Clyde, and was funded by Scottish Enterprise and Cell & Gene Catalyst UK.

The Atrial Fibrillation (AF) project, a collaboration between DHI, NHS Lanarkshire, the University of Strathclyde, Napier University, and Bardy, aimed to detect paroxysmal AF using continuous monitoring devices. It focused on reducing stroke recurrence and supporting new stroke standards through co-design and evaluating digital device implementation.

The Personal Data Store (PDS), or "Backpack," aimed to enhance service access and enable integrated, person-centred care. In partnership with Mydex CIC, NHS Grampian, and Moray Social Health and Care Partnership, DHI worked with MS patients and professionals to improve personal information management for better service experiences.

This project repurposed the DHI-funded Trauma App to assess COVID-19 symptoms, deployed by NHS Greater Glasgow & Clyde. It facilitated 20,000 assessments by July 2021. Version 3 was completed, and a Stage 4 proposal was prepared before the project closed in October 2021.

This project expanded the National Notification Service (NSS) by adding a self-service contact tracing form, crucial to the COVID-19 response. It facilitated rapid data collection and improved accessibility for positive cases.